Aquestive Therapeutics Inc (AQST)

Investing Cash Flow

-$584.00K

TTM · Period ending: · USD

AQST logo

AQST Investing Cash Flow

Latest reported-$584.00K
AQST TTM Cash from Investing (-$2.07M → -$584.00K)
High-resolution chart · PNG

AQST investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aquestive Therapeutics Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-584,000
-479,000
-562,000
-492,000
-337,000
-265,000
-159,000
-160,000
-231,000
-1,022,000
-995,000
-1,005,000
-2,571,000
-2,422,000
-2,524,000
-3,031,000
-1,397,000
-914,000
-913,000
-616,000
-571,000
-489,000
-517,000
-367,000
-420,000
-418,000
-663,000
-1,067,000
-1,424,000
-1,941,000
-1,824,000
-1,422,000
-1,407,000
-1,670,000
-2,068,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.